...
首页> 外文期刊>Journal of Surgical Oncology >Is transureteroureterostomy performed during multi-organ resection for non-urothelial malignancy safe and effective?
【24h】

Is transureteroureterostomy performed during multi-organ resection for non-urothelial malignancy safe and effective?

机译:在多器官切除术中进行非输尿管上皮恶性肿瘤的输尿管输尿管造口术安全有效吗?

获取原文
获取原文并翻译 | 示例

摘要

Background: Multi-organ resection in patients with non-urothelial cancer may include segmental ureteral resection. The resulting ureteral defect can be reconstructed with a transureteroureterostomy (TUU); however, whether TUU is safe and effective in this patient group remains unclear. Objectives: In the current retrospective analysis, we evaluated renal function before and after complex multi-organ resection that included TUU to determine whether TUU is safe and effective. Methods: We retrospectively reviewed the charts of patients who underwent TUU between 1995 and 2011. Renal imaging studies performed before and after TUU were used to determine whether hydronephrosis was present in either kidney. Kidney function was assessed by measuring serum creatinine levels and calculating the estimated glomerular filtration rate (eGFR) before and after TUU. Results: Twelve patients underwent TUU during multiorgan resection. Median follow-up time was 15 months. Three patients with cancer recurrence involving the TUU developed progressive hydronephrosis. Serum creatinine levels did not increase more than 0.5 mg/dl in any patient. Kidney function as assessed by eGFR was maintained in all patients (until the time of recurrence in the three patients with recurrence affecting the TUU). Conclusions: TUU during multi-organ resection for non-urothelial malignancy is safe and effective. Long-term renal function is maintained in the majority of patients.
机译:背景:非尿路上皮癌患者的多器官切除术可能包括分段输尿管切除术。由此产生的输尿管缺损可以通过输尿管输尿管造口术(TUU)重建;但是,TUU在该患者组中是否安全有效仍不清楚。目的:在当前的回顾性分析中,我们评估了包括TUU在内的复杂多器官切除术前后的肾功能,以确定TUU是否安全有效。方法:我们回顾性回顾了1995年至2011年接受TUU手术的患者的病历。使用TUU前后进行的肾脏影像学检查来确定两个肾脏中是否存在肾积水。通过测量血清肌酐水平并计算TUU前后的肾小球滤过率(eGFR)来评估肾脏功能。结果:十二名患者在多器官切除术中接受了TUU。中位随访时间为15个月。三名涉及TUU的癌症复发患者发展为进行性肾积水。任何患者的血清肌酐水平增加不超过0.5 mg / dl。通过eGFR评估的肾功能在所有患者中均得以维持(直到三名复发的时间影响TUU的患者复发)。结论:非尿路上皮恶性肿瘤多器官切除术中TUU是安全有效的。大多数患者维持长期肾功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号